These observations are consistent with previous reports demonstrating that MGL engagement with GalNac-carrying tumor-associated antigens or anti-MGL antibodies induced the phosphorylation of ERK1/2, c-Jun and NFκ-B activation in human DCs [31,41]. Here, MAPK3 is linked to neoplasm.